title: Re: Review article titled 'Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia' (Stevens GL et al. Early Interv Psychiatry 2015 Sep 25. doi: 10.1111/eip.12278).
authors.affiliation: Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
authors.forename: Larry
authors.initials: L
authors.lastname: Alphs
authors.affiliation: Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Bossie
authors.affiliation: Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
authors.forename: Jennifer Kern
authors.initials: JK
authors.lastname: Sliwa
mesh_terms: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D006801:Humans; D018967:Risperidone; D012559:Schizophrenia
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone